BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 1169869)

  • 1. Cell mediated immunity in experimental infection with Semliki forest virus in mice.
    Likar M; Kovic M; Pustovrh B; Sok M
    Acta Med Iugosl; 1975; 29(2):127-33. PubMed ID: 1169869
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunogenicity and protective efficacy of Semliki forest virus replicon-based DNA vaccines encoding goatpox virus structural proteins.
    Zheng M; Jin N; Liu Q; Huo X; Li Y; Hu B; Ma H; Zhu Z; Cong Y; Li X; Jin M; Zhu G
    Virology; 2009 Aug; 391(1):33-43. PubMed ID: 19559453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary evidence for cell-mediated immunity in cross-protection among group A arboviruses.
    Peck RD; Brown A; Wust CJ
    J Immunol; 1975 Feb; 114(2 Pt 1):581-4. PubMed ID: 1079033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The antibody titer and fluorescence suitability of semliki forest virus immune sera (author's transl)].
    Weiland E
    Zentralbl Bakteriol Orig A; 1974; 229(1):37-44. PubMed ID: 4155207
    [No Abstract]   [Full Text] [Related]  

  • 5. Semliki forest virus and Kunjin virus RNA replicons elicit comparable cellular immunity but distinct humoral immunity.
    Tannis LL; Gauthier A; Evelegh C; Parsons R; Nyholt D; Khromykh A; Bramson JL
    Vaccine; 2005 Jul; 23(33):4189-94. PubMed ID: 16005737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simple method for preparation of immune sera to envelope and nucleocapsid antigens of Semliki Forest virus.
    Gaidamovich SY; Melnikova EE; Krasnobaeva ZN
    Acta Virol; 1977 Jul; 21(4):347-8. PubMed ID: 20771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient expansion of HIV-1-specific T cell responses by homologous immunization with recombinant Semliki Forest virus particles.
    Sundbäck M; Douagi I; Dayaraj C; Forsell MN; Nordström EK; McInerney GM; Spångberg K; Tjäder L; Bonin E; Sundström M; Liljeström P; Karlsson Hedestam GB
    Virology; 2005 Oct; 341(2):190-202. PubMed ID: 16098555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The sensitivity to gamma-irradiation of the phases of the virus-host interaction: studies with strains of Semliki forest virus in mice.
    Bradish CJ; Titmuss D; Fitzgeorge R
    J Gen Virol; 1980 May; 48(1):39-51. PubMed ID: 7381435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of liposomal charge on the neutralizing antibody response against inactivated encephalomyocarditis and Semliki Forest viruses.
    Kraaijeveld CA; Schilham M; Jansen J; Benaissa-Trouw B; Harmsen M; van Houte AJ; Snippe H
    Clin Exp Immunol; 1984 Jun; 56(3):509-14. PubMed ID: 6086188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Host defenses during primary Venezuelan equine encephalomyelitis virus infection in mice. II. In vitro methods for the measurement and qualitation of the immune response.
    Adler WH; Rabinowitz SG
    J Immunol; 1973 May; 110(5):1354-62. PubMed ID: 4697832
    [No Abstract]   [Full Text] [Related]  

  • 11. Aspects of monoclonal antibody-mediated protection of mice against infection with virulent Semliki Forest virus.
    Boere WA; Kraaijeveld CA; Snippe H
    Antiviral Res; 1985; Suppl 1():149-53. PubMed ID: 2417548
    [No Abstract]   [Full Text] [Related]  

  • 12. Delayed multiplication of Semliki forest virus in organ cultures of muscle from vaccinated mice.
    van der Groen G; Pattyn SR
    Zentralbl Bakteriol Orig A; 1976 Nov; 236(2-3):145-9. PubMed ID: 1015007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of genetic variants of the poliomyelitis viruses on the cellular and humoral immunity factors in mice].
    Shirobokov VP; Korniushenko ON; Negrebetskaia EN
    Mikrobiol Zh (1978); 1986; 48(2):63-7. PubMed ID: 2855847
    [No Abstract]   [Full Text] [Related]  

  • 14. Enhancing immune responses using suicidal DNA vaccines.
    Berglund P; Smerdou C; Fleeton MN; Tubulekas I; Liljeström P
    Nat Biotechnol; 1998 Jun; 16(6):562-5. PubMed ID: 9624688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study on experimental vaccinia virus infection in mice with special reference to host defence mechanisms.
    Prasad CB; Hedström KG
    Z Immunitatsforsch Exp Klin Immunol; 1974 Nov; 148(2):97-111. PubMed ID: 4377639
    [No Abstract]   [Full Text] [Related]  

  • 16. Dimethyl dioctadecyl ammoniumbromide as an adjuvant for delayed type hypersensitivity and cellular immunity against Semliki Forest virus in mice.
    Kraaijeveld CA; Snippe H; Harmsen M; Khader Boutahar-Trouw B
    Arch Virol; 1980; 65(3-4):211-7. PubMed ID: 7416968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serological examinations for antibodies against West Nile virus, Semlikivirus and chikungunyavirus in laboratory mice, parasitized by nidicole fauna from swallow's nests.
    Sixl W; Stünzner D; Withalm H
    Geogr Med Suppl; 1988; 1():51-5. PubMed ID: 3139492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain viral persistence and myelin damage in nude mice.
    Chew-Lim M
    Can J Comp Med; 1979 Jan; 43(1):39-43. PubMed ID: 427638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular immunity against Semliki Forest virus in mice.
    Kraaijeveld CA; Harmsen M; Khader Boutahar-Trouw B
    Infect Immun; 1979 Feb; 23(2):213-8. PubMed ID: 311341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reconstitution of Semliki forest virus infected mice, induces immune mediated pathological changes in the CNS.
    Fazakerley JK; Amor S; Webb HE
    Clin Exp Immunol; 1983 Apr; 52(1):115-20. PubMed ID: 6305540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.